Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.
作者信息
Lacout Alexis, Marcy Pierre Yves, Perronne Christian
机构信息
Centre de Diagnostic, ELSAN, Centre Médico-Chirurgical, 83 avenue Charles de Gaulle, 15000 Aurillac, France.
Radiodiagnostics and Interventional Radiology Department, ELSAN, Polyclinique Les Fleurs, Quartier Quiez, 83190 Ollioules, France.
出版信息
Clin Microbiol Infect. 2021 Jan;27(1):134-135. doi: 10.1016/j.cmi.2020.09.027. Epub 2020 Sep 25.
Abstract
摘要
相似文献
1
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.回复：菲奥莱特等人所著的《羟氯喹啉联合或不联合阿奇霉素对COVID-19患者死亡率的影响》
Clin Microbiol Infect. 2021 Jan;27(1):134-135. doi: 10.1016/j.cmi.2020.09.027. Epub 2020 Sep 25.
2
Re: 'Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients' by Fiolet et al.回复：菲奥莱特等人所著的《羟氯喹啉联合或不联合阿奇霉素对COVID-19患者死亡率的影响》
Clin Microbiol Infect. 2021 Jan;27(1):132-133. doi: 10.1016/j.cmi.2020.09.026. Epub 2020 Sep 24.
3
Re: Effect of hydroxychloroquine with or without azithromycin on the mortality of COVID-19 patients: a systematic review and meta-analysis' by Fiolet et al.关于：菲奥莱特等人的《羟氯喹联合或不联合阿奇霉素对COVID-19患者死亡率的影响：系统评价与荟萃分析》
Clin Microbiol Infect. 2021 Jun;27(6):918-919. doi: 10.1016/j.cmi.2020.10.018. Epub 2020 Oct 28.
4
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection.对于重症新冠病毒感染患者，没有证据表明羟氯喹和阿奇霉素联合使用能实现快速的抗病毒清除或带来临床益处。
Med Mal Infect. 2020 Jun;50(4):384. doi: 10.1016/j.medmal.2020.03.006. Epub 2020 Mar 30.
5
Proactive prophylaxis with azithromycin and hydroxychloroquine in hospitalized patients with COVID-19 (ProPAC-COVID): a statistical analysis plan.COVID-19 住院患者中阿奇霉素和羟氯喹的主动预防（ProPAC-COVID）：统计分析计划。
Trials. 2020 Oct 20;21(1):867. doi: 10.1186/s13063-020-04795-0.
6
Hydroxychloroquine as prophylaxis or treatment for COVID-19: What does the evidence say?羟氯喹作为 COVID-19 的预防或治疗药物：证据说了什么？
Indian J Public Health. 2020 Jun;64(Supplement):S125-S127. doi: 10.4103/ijph.IJPH_496_20.
7
Response to the use of hydroxychloroquine in combination with azithromycin for patients with COVID-19 is not supported by recent literature.近期文献不支持将羟氯喹与阿奇霉素联合用于治疗COVID-19患者。
Int J Antimicrob Agents. 2021 Jan;57(1):106241. doi: 10.1016/j.ijantimicag.2020.106241.
8
Azithromycin added to hydroxychloroquine for patients admitted to intensive care due to coronavirus disease 2019 (COVID-19)-protocol of randomised controlled trial AZIQUINE-ICU.阿奇霉素联合羟氯喹治疗因 2019 冠状病毒病（COVID-19）入住重症监护病房的患者：随机对照试验 AZIQUINE-ICU 的方案。
Trials. 2020 Jul 8;21(1):631. doi: 10.1186/s13063-020-04566-x.
9
Hydroxychloroquine + azithromycin treatment in elderly patients.老年患者的羟氯喹啉 + 阿奇霉素治疗
Int J Antimicrob Agents. 2021 Apr;57(4):106313. doi: 10.1016/j.ijantimicag.2021.106313. Epub 2021 Mar 11.
10
Audio Interview: Studying Potential Covid-19 Therapies.音频访谈：研究潜在的新冠病毒治疗方法。
N Engl J Med. 2020 May 7;382(19):e72. doi: 10.1056/NEJMe2015955.
引用本文的文献
1
Difficult editorial decisions.艰难的编辑决策。
Clin Microbiol Infect. 2021 Jan;27(1):1-2. doi: 10.1016/j.cmi.2020.10.013. Epub 2020 Oct 27.
本文引用的文献
1
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis.羟氯喹联合或不联合阿奇霉素对 COVID-19 患者死亡率的影响：系统评价和荟萃分析。
Clin Microbiol Infect. 2021 Jan;27(1):19-27. doi: 10.1016/j.cmi.2020.08.022. Epub 2020 Aug 26.
2
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study.羟氯喹在住院 COVID-19 患者中的应用与降低死亡率相关：来自意大利 CORIST 观察性多中心研究的结果。
Eur J Intern Med. 2020 Dec;82:38-47. doi: 10.1016/j.ejim.2020.08.019. Epub 2020 Aug 25.
3
Low-dose hydroxychloroquine therapy and mortality in hospitalised patients with COVID-19: a nationwide observational study of 8075 participants.低剂量羟氯喹治疗对 COVID-19 住院患者死亡率的影响：一项全国性观察研究，纳入 8075 名参与者。
Int J Antimicrob Agents. 2020 Oct;56(4):106144. doi: 10.1016/j.ijantimicag.2020.106144. Epub 2020 Aug 24.
4
Impact of medical care, including use of anti-infective agents, on prognosis of COVID-19 hospitalized patients over time.随着时间的推移，医疗护理（包括抗感染药物的使用）对 COVID-19 住院患者预后的影响。
Int J Antimicrob Agents. 2020 Oct;56(4):106129. doi: 10.1016/j.ijantimicag.2020.106129. Epub 2020 Aug 2.
5
Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19 : A Randomized Trial.羟氯喹治疗非住院的 COVID-19 轻症成年患者：一项随机试验。
Ann Intern Med. 2020 Oct 20;173(8):623-631. doi: 10.7326/M20-4207. Epub 2020 Jul 16.
Zotero 插件